| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | Incivo (EU), Incivek (US) | |
| 3 | Generic Name | telaprevir | |
| 4 | Mechanism | Protease Inhibitor | |
| 5 | Economics | VRTX US, JNJ Ex-US/Japan. | |
| 6 | Clinical Trials | ||
| 7 | Phase III ADVANCE | ||
| 8 | 75% SVR in 12-week versus 44% in control. |
| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | Incivo (EU), Incivek (US) | |
| 3 | Generic Name | telaprevir | |
| 4 | Mechanism | Protease Inhibitor | |
| 5 | Economics | VRTX US, JNJ Ex-US/Japan. | |
| 6 | Clinical Trials | ||
| 7 | Phase III ADVANCE | ||
| 8 | 75% SVR in 12-week versus 44% in control. |
Martin Shkreli